XOMA Royalty Corp — Form SCHEDULE 13D/A
Filed July 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
BIOTECHNOLOGY VALUE FUND L.P. filed an amended Schedule 13D/A regarding XOMA Royalty Corp on July 16, 2026. The filing header and administrative details are present, but the actual amendment content — including the specific changes to beneficial ownership, share counts, percentages, or transaction details — is not included in the document text provided.
Why this rating
Without substantive amendment content (shares, %, dates, changes), cannot assess materiality. Schedule 13D amendments are routine disclosures unless they signal major stake changes.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.